Summary: ResAppDx is Australia’s only TGA approved, clinically validated remote respiratory cough test. Developed by ResApp Health, ResAppDx analyses cough sounds using clinically validated algorithms to provide indications for lower respiratory tract disease, pneumonia, asthma/reactive airway disease exacerbations, COPD exacerbations, bronchiolitis and croup.